Skip to main content
Premium Trial:

Request an Annual Quote

Lifebit Lands $3M in Seed Funding, Launches Genomic Analysis Platform

NEW YORK (GenomeWeb) – Lifebit, a London-based maker of advanced genomic analysis technology, has raised $3 million in seed funding and introduced its first product. Pentech and Connect Ventures led the investment, with participation from Beacon Capital and crowdsourcing angel investment site Tiny VC.

The product, called Deploit, is a cloud-based genomic analysis platform featuring artificial intelligence technology. Lifebit called Deploit the first step toward its goal to create a "cognitive system that can reason about DNA data in the same way as humans," making such analysis technology accessible to people without informatics training.

Several unspecified pharmaceutical and biotech companies are testing Deploit, Lifebit said.

"The problem these organizations face is no longer sequencing vast quantities of genomic data, but rather making sense of this data quickly and affordably," Lifebit CEO and Cofounder Maria Chatzou said in statement. "This requires new data analysis technologies, which is where Lifebit comes in. Our mission as a company is to enable cloud-based real-time genomic analysis at scale, anywhere, by anyone."

Chatzou and Chief Technology Officer Pablo Prieto Barja started Lifebit a year ago in Cambridge, UK, after having studied for PhDs together at the Centre for Genomic Regulation in Barcelona. The pair were part of the team that created Nextflow, a widely used open-source platform to automate DNA analysis. 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.